Medical liability current.

No definition available.

Name:	ameh_MedicalLiabilityCurrent
Namespace Prefix:	ameh_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage for Down round financing.

+ References

No definition available.

+ Details

Name:	ameh_PercentageForDownRoundFinancing
Namespace Prefix:	ameh_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of accounts receivable from customers

+ References

No definition available.

+ Details

Name:	ameh_PercentageOfAccountsReceivableFromCustomers
Namespace Prefix:	ameh_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Revenue of major customers percentage of total revenue

+ References

No definition available.

+ Details

Name:	ameh_RevenueOfMajorCustomersPercentageOfTotalRevenue
Namespace Prefix:	ameh_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Service Agreement Term

+ References

No definition available.

+ Details

Name:	ameh_ServiceAgreementTerm
Namespace Prefix:	ameh_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ameh_SummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix:	ameh_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The price per share of the conversion feature embedded in the debt instrument.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928298&loc=SL6031898-161870

+ Details

Name:	us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_FinancialLiabilitiesFairValueDisclosure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8184-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8195-115640

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35755915&loc=SL9156464-115641

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name:	us-gaap_HealthCareOrganizationPatientServiceRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name:	us-gaap_ProceedsFromPaymentsToMinorityShareholders
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.D.2)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section D

-Subsection 2

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	dei_LegalEntityAxis=ameh_ApollomedAcoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=ameh_NnaFinancing2014Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=ameh_NnaFinancingEightPercentageConvertibleNote2014Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_CustomerAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_CustomerBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_CustomerCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ameh_Nna8ConvertibleNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ameh_ThreeMajorCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended				3 Months Ended	9 Months Ended		12 Months Ended	3 Months Ended
	Dec. 13, 2014	Nov. 18, 2014	Oct. 31, 2014	Jul. 31, 2014	Mar. 28, 2014	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2014
Summary Of Significant Accounting Policies [Line Items]
Expected term	6 years	6 years	6 years	6 years	7 years	6 years
Risk free interest rate	1.63%	1.60%	1.60%	1.63%	2.31%	1.60%
Expected volatility rate	62.90%	62.90%	62.90%	63.70%	71.40%	62.90%
Expected dividend rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Share Price	$ 0.39us-gaap_SharePrice	$ 0.39us-gaap_SharePrice	$ 0.43us-gaap_SharePrice	$ 0.54us-gaap_SharePrice		$ 0.39us-gaap_SharePrice	$ 0.39us-gaap_SharePrice
Health Care Organization, Patient Service Revenue							$ 20,000
Medical Liability Current						1,805,554ameh_MedicalLiabilityCurrent	1,805,554ameh_MedicalLiabilityCurrent		552,561ameh_MedicalLiabilityCurrent
non-controlling interest							586,111	0
Financial Liabilities Fair Value Disclosure						3,316,067	3,316,067
Convertible Notes Payable [Member]
Summary Of Significant Accounting Policies [Line Items]
Debt Instrument, Interest Rate, Stated Percentage					8.00%
2014 NNA Financing
Summary Of Significant Accounting Policies [Line Items]
Expected term							6 years 2 months 12 days		7 years
Risk free interest rate							1.83%		2.31%
Expected volatility rate							71.90%		71.40%
Expected dividend rate							0.00%		0.00%
Share Price						$ 0.38	$ 0.38		$ 0.45
Percentage For Down round financing							100.00%		50.00%
Financial Liabilities Fair Value Disclosure						2,452,201	2,452,201		2,354,624
2014 NNA Financing 8% Convertible Note
Summary Of Significant Accounting Policies [Line Items]
Expected term							4 years 2 months 12 days
Risk free interest rate							1.40%
Expected volatility rate							55.40%
Expected dividend rate							0.00%
Share Price						$ 0.38	$ 0.38
Percentage For Down round financing							100.00%
Debt Instrument, Interest Rate, Stated Percentage						8.00%	8.00%
Debt Instrument, Convertible, Conversion Price						$ 1.00	$ 1.00
Financial Liabilities Fair Value Disclosure						487,630	487,630
Maximum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term							20 years
Minimum
Summary Of Significant Accounting Policies [Line Items]
Management agreement, initial term							10 years
Three Major Customers
Summary Of Significant Accounting Policies [Line Items]
Percentage Of Accounts Receivable From Customers									19.50%
NNA 8 Convertible Notes
Summary Of Significant Accounting Policies [Line Items]
Expected dividend rate				0.00%
Share Price						$ 0.45	$ 0.45
Customer A \| Two Major Customers
Summary Of Significant Accounting Policies [Line Items]
Revenue Of Major Customers Percentage Of Total Revenue						29.60%	41.20%
Customer A \| Three Major Customers
Summary Of Significant Accounting Policies [Line Items]
Revenue Of Major Customers Percentage Of Total Revenue								15.90%		15.20%
Percentage Of Accounts Receivable From Customers						22.70%	22.70%
Customer B \| Two Major Customers
Summary Of Significant Accounting Policies [Line Items]
Revenue Of Major Customers Percentage Of Total Revenue						25.30%	22.20%
Customer B \| Three Major Customers
Summary Of Significant Accounting Policies [Line Items]
Revenue Of Major Customers Percentage Of Total Revenue								15.50%		14.80%
Percentage Of Accounts Receivable From Customers						16.20%	16.20%
Customer C \| Three Major Customers
Summary Of Significant Accounting Policies [Line Items]
Revenue Of Major Customers Percentage Of Total Revenue								15.20%		14.30%
ApolloMed ACO
Summary Of Significant Accounting Policies [Line Items]
Health Care Organization, Patient Service Revenue							$ 5.38				$ 10,980,000